BRIEF-ExpreS2ion Announces SEK 6.7 Mln Grant For Development Influenza Vaccine - Reuters

March 31 (Reuters) - ExpreS2ion Biotech Holding AB :

* EXPRES2ION ANNOUNCES 6.7 MSEK EU HORIZON 2020 GRANT FOR THE DEVELOPMENT OF A UNIQUE INFLUENZA VACCINE

* GRANT, IS ESTIMATED TO BE RECOGNISED AS REVENUE EVENLY FROM H2 2020 THROUGH H2 2021 Source text for Eikon: Further company coverage: (Gdansk Newsroom)

Our Standards:The Thomson Reuters Trust Principles.


Comments

Popular posts from this blog

180+ chief medical officers to know | 2025

Primary Care - North Greece Internal Medicine & Pediatrics

Recommended Adult Immunization Schedule, United States, 2020* | Annals of Internal Medicine